AGTR1 and Hypertension: Importantly, β-arrestin1 was confirmed to downregulate AT1R expression in SHR, suggesting that upregulation of ß-arrestin1 is a potential strategy to lower AT1R expression and ameliorate sympathetic vasomotor tone in hypertension.